All In Biotech

Drug Trial Radar · NCT03952299

Oxybutynin for Post-surgical Bladder Pain and Urgency

Last checked: Nov 20, 2026Latest source record: Jan 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 100 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

100

Planned (sponsor's estimate)

Start

Sep 1, 2021

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
University of California, DavisAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
May 16, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years, up to 8 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Bladder pain and urgency are common after bladder surgery. The objective is to determine if transdermal administration is superior to oral administration in alleviating pain and urgency.

Conditions

  • Overactive Bladder Syndrome
  • Neuropathic Bladder

Interventions

  • Oxybutynin Transdermal PatchDrug

    Transdermal patch of oxybutynin will be used instead of oral oxybutynin.

  • Oral OxybutyninDrug

    Oral administration of oxybutynin (5mg) every 8 hours in the hospital.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Urgency ScoresTime frame: Preoperative (one week to two months) to postoperative period (six weeks).
  2. Pain ScoresTime frame: Preoperative (one week to two months) to postoperative period (six weeks).
  3. Narcotic UsageTime frame: Postoperative (six weeks)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • University of California Davis Medical Center (UCDMC)

    Sacramento, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.